Comparative immunogenicities of Vi polysaccharide-protein conjugates composed of cholera toxin or its B subunit as a carrier bound to high- or lower-molecular-weight Vi
- PMID: 2807549
- PMCID: PMC259911
- DOI: 10.1128/iai.57.12.3823-3827.1989
Comparative immunogenicities of Vi polysaccharide-protein conjugates composed of cholera toxin or its B subunit as a carrier bound to high- or lower-molecular-weight Vi
Abstract
The effect of molecular weight or size of the components on the immunogenicity of polysaccharide-protein conjugates prepared with the native Vi capsular polysaccharide (Vi) (approximately 3 x 10(3) kilodaltons) or lower-molecular-weight Vi (Vis; approximately 46 kilodaltons) abound to cholera toxin (CT) or to its B subunit (CTB) was studied. In mice, Vi-CT, Vi-CTB, and Vis-CTB elicited higher Vi antibody levels than the Vi alone (P less than 0.0001). Vi-CT and Vi-CTB were more immunogenic than Vis-CTB (P less than 0.01). CT or Vi-CT elicited higher levels of CT antibodies, as measured by enzyme-linked immunosorbent assay, than did CTB or Vi-CTB. In rhesus monkeys, the Vi conjugates elicited higher Vi antibody levels than the Vi alone (P less than 0.01). Vi-CTB elicited higher levels of Vi antibody after each injection than did Vis-CTB. Similar levels of CT antibodies, as measured by enzyme-linked immunosorbent assay, were elicited by all three conjugates. In contrast, Vi-CT elicited higher levels of neutralizing antibodies than Vi-CTB or Vis-CTB when either CT or the related heat-labile toxin of Escherichia coli was used as the antigen. These results indicate that the holotoxin and the native Vi provide the most immunogenic components for conjugates designed to induce both Vi and CT antibodies.
Similar articles
-
Physical and chemical characterization and immunologic properties of Salmonella enterica serovar typhi capsular polysaccharide-diphtheria toxoid conjugates.Clin Vaccine Immunol. 2010 Jan;17(1):73-9. doi: 10.1128/CVI.00266-09. Epub 2009 Nov 4. Clin Vaccine Immunol. 2010. PMID: 19889941 Free PMC article.
-
Vi capsular polysaccharide-protein conjugates for prevention of typhoid fever. Preparation, characterization, and immunogenicity in laboratory animals.J Exp Med. 1987 Nov 1;166(5):1510-24. doi: 10.1084/jem.166.5.1510. J Exp Med. 1987. PMID: 3681191 Free PMC article.
-
Laboratory and preliminary clinical characterization of Vi capsular polysaccharide-protein conjugate vaccines.Infect Immun. 1994 Oct;62(10):4440-4. doi: 10.1128/iai.62.10.4440-4444.1994. Infect Immun. 1994. PMID: 7927707 Free PMC article.
-
A review of the current status of enteric vaccines.P N G Med J. 1995 Dec;38(4):325-31. P N G Med J. 1995. PMID: 9522876 Review.
-
Reexamination of the protective role of the capsular polysaccharide (Vi antigen) of Salmonella typhi.J Infect Dis. 1984 Sep;150(3):436-49. doi: 10.1093/infdis/150.3.436. J Infect Dis. 1984. PMID: 6207249 Review.
Cited by
-
Comparative immunogenicity of conjugates composed of the Staphylococcus aureus type 8 capsular polysaccharide bound to carrier proteins by adipic acid dihydrazide or N-succinimidyl-3-(2-pyridyldithio)propionate.Infect Immun. 1992 Feb;60(2):584-9. doi: 10.1128/iai.60.2.584-589.1992. Infect Immun. 1992. PMID: 1730492 Free PMC article.
-
Epitope specificities of the group Y and W-135 polysaccharides of Neisseria meningitidis.Clin Vaccine Immunol. 2007 Oct;14(10):1311-7. doi: 10.1128/CVI.00049-07. Epub 2007 Sep 5. Clin Vaccine Immunol. 2007. PMID: 17804612 Free PMC article.
-
Laboratory and clinical evaluation of conjugate vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides bound to Pseudomonas aeruginosa recombinant exoprotein A.Infect Immun. 1993 Mar;61(3):1023-32. doi: 10.1128/iai.61.3.1023-1032.1993. Infect Immun. 1993. PMID: 8432585 Free PMC article.
-
The influence of conjugation variables on the design and immunogenicity of a glycoconjugate vaccine against Salmonella Typhi.PLoS One. 2017 Dec 29;12(12):e0189100. doi: 10.1371/journal.pone.0189100. eCollection 2017. PLoS One. 2017. PMID: 29287062 Free PMC article.
-
Physical and chemical characterization and immunologic properties of Salmonella enterica serovar typhi capsular polysaccharide-diphtheria toxoid conjugates.Clin Vaccine Immunol. 2010 Jan;17(1):73-9. doi: 10.1128/CVI.00266-09. Epub 2009 Nov 4. Clin Vaccine Immunol. 2010. PMID: 19889941 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources